- Home
- UMAC vs PRME Comparison
UMAC vs PRME Comparison
Compare UMAC & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.76
Company Overview
Basic Information| Metric | UMAC | PRME |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.2M | 666.1M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UMAC | PRME |
|---|---|---|
| Price | $15.12 | $3.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $20.00 | $7.56 |
| AVG Volume (30 Days) | ★ 4.6M | 2.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.73 | 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,199,217.00 | $4,632,000.00 |
| Revenue This Year | $115.39 | $12.41 |
| Revenue Next Year | $101.44 | $52.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 101.23 | 55.28 |
| 52 Week Low | $4.67 | $1.11 |
| 52 Week High | $23.38 | $6.94 |
Technical Indicators
Market Signals| Indicator | UMAC | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 55.34 |
| Support Level | $8.29 | $3.73 |
| Resistance Level | $16.52 | $3.94 |
| Average True Range (ATR) | 1.43 | 0.26 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 98.76 | 86.75 |
Price Performance
Historical Comparison UMAC
PRME
About UMAC Unusual Machines Inc.
Unusual Machines Inc is engaged in manufactures and sells drone components and drones across a diversified brand portfolio through business-to-business (B2B) sales and a curated retail channel.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.